XRN Chiron Real Estate Inc.

CIK 0001533615 50 ready 8-Ks latest July 6, 2026, 4:30 PM ET RSS · JSON

Activity: NORMAL 2 filings / 30d vs 1 baseline

Ready 8-Ks 50

Latest filing July 6, 2026, 4:30 PM ET

Top materiality 0.90

Event mix other_material ×16 · earnings ×16 · leadership ×6

Sentiment 8 pos · 8 neg · 34 neu

Latest earnings reported 2025-FY

Executive change recent →

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for XRN

Highest-materiality recent filing

Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%

May 6, 2026, 7:59 PM ET M&A materiality 0.90 positive item 1.01 item 2.02 item 7.01 item 8.01 item 9.01 ◈ Material Agreements ×3◈ Earnings Releases

Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
Secured $100M convertible preferred equity from Maewyn Capital Partners at 6.00%, initial conversion $43/share.

Read filing →

July 6, 2026, 4:30 PM ET other material materiality 0.70 positive item 7.01 item 9.01

Chiron Real Estate acquires SHOP assets for $249M, forms IRF JV for ~$200M, pending Pinnacle acquisition

Acquired The Riviera and The Landing SHOP communities in June 2026 for $249M total; Riviera 23% occupied, Landing 93% occupied.
July 2, 2026, 5:26 PM ET M&A materiality 0.75 neutral item 1.01 item 2.01 item 9.01

Chiron Real Estate sells seven rehab hospitals for $217M, retains 15% JV interest

Sold seven inpatient rehabilitation hospitals in PA, AZ, TX, NV, OK for $217M; closed June 29, 2026.
June 2, 2026, 4:30 PM ET M&A materiality 0.85 positive item 1.01 item 2.01 item 2.03 item 3.02 item 3.03 item 5.03 item 9.01 ◈ Equity Issuances ×2◈ M&A Transactions ×2◈ Debt Financings◈ Governance Changes◈ Material Agreements

Chiron Real Estate closes $249M acquisition of two senior housing communities; issues $100M Series C preferred

Acquired The Landing Alexandria ($130M) and The Riviera Alexandria ($118.9M) on June 1, 2026.
May 20, 2026, 5:24 PM ET leadership materiality 0.50 neutral item 5.02 item 1.01 item 5.07 item 7.01 item 9.01 ◈ Shareholder Votes ×4◈ executive_change

Chiron appoints Charles Fitzgerald to board; declares Q2 preferred dividends

Charles Fitzgerald appointed to Board effective May 20, 2026; serves on Compensation and Nominating Committees.
May 8, 2026, 7:59 PM ET other material materiality 0.75 neutral item 1.01 item 3.02 item 9.01 ◈ Material Agreements ×2◈ Equity Issuances

Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP

Company enters $100M preferred equity purchase agreement with Maewyn XRN LP; initial closing of at least $25M by June 20, 2026.
May 6, 2026, 7:59 PM ET M&A materiality 0.90 positive item 1.01 item 2.02 item 7.01 item 8.01 item 9.01 ◈ Material Agreements ×3◈ Earnings Releases

Chiron signs $425M senior housing acquisitions, $100M equity investment, cuts dividend 36%

Agreed to acquire three senior housing communities in DC metro for ~$425M, expected to close in Q2/Q4 2026.
March 13, 2026, 7:59 PM ET other material materiality 0.45 neutral item 1.01 item 5.03 item 8.01 item 9.01 ◈ Governance Changes◈ Material Agreements

Chiron Real Estate files for up to $75M Preferred ATM and updates Common ATM with $288M remaining

Preferred ATM program launched for up to $75M of Series B Preferred Stock; agents get up to 2.0% commission.
March 3, 2026, 6:59 PM ET debt materiality 0.55 neutral item 1.01 item 2.03 item 9.01 ◈ Debt Financings◈ Material Agreements

Chiron Real Estate enters $150M uncommitted senior note facility with NYL Investors

Master Note and Guaranty Agreement with NYL Investors LLC establishes uncommitted facility for up to $150M aggregate principal.
February 25, 2026, 6:59 PM ET earnings materiality 0.70 neutral item 2.02 item 5.03 item 7.01 item 8.01 item 9.01 ◈ Governance Changes

Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend

Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
January 26, 2026, 6:59 PM ET leadership materiality 0.35 neutral item 5.02

Director Henry Cole to step down at 2026 Annual Meeting

Henry Cole notified Board he will leave as director effective at 2026 Annual Meeting.
December 4, 2025, 6:59 PM ET leadership materiality 0.15 neutral item 5.02

Director Ronald Marston to retire at 2026 annual meeting

Ronald Marston notified board on December 3, 2025 of intent to retire as director.
November 18, 2025, 6:59 PM ET debt materiality 0.60 neutral item 1.01 item 3.03 item 5.03 item 9.01 ◈ Equity Issuances◈ Governance Changes

Global Medical REIT to issue 2M shares of 8.00% Series B Preferred Stock at $25/share

Offering of 2,000,000 shares (plus 300,000 over-allotment) of 8.00% Series B cumulative redeemable preferred stock at $25.00 per share.
November 13, 2025, 6:59 PM ET earnings materiality 0.75 negative item 8.01

Global Medical REIT Q3 2025 net loss of $6.0M vs income $1.8M YoY; occupancy 95.2%

Net loss $6.0M ($0.45/diluted share) vs net income $1.8M ($0.14) in Q3 2024.
November 4, 2025, 6:59 PM ET earnings materiality 0.75 negative item 2.02 item 9.01

Global Medical REIT Q3 net loss $6.0M vs income $1.8M; FFO/AFFO up 4%; narrows 2025 AFFO guidance

Net loss $6.0M ($0.45/diluted) vs net income $1.8M ($0.14); includes $6.3M impairment on sold Aurora, IL property.
October 8, 2025, 7:59 PM ET debt materiality 0.65 positive item 1.01 item 2.03 item 7.01 item 9.01

Global Medical REIT amends credit facility, extends maturities to 2029-2031, enters $350M hedges

$400M revolver maturity extended to Oct 2029 with two six-month extension options to Oct 2030.
September 19, 2025, 7:59 PM ET other material materiality 0.50 neutral item 3.03 item 5.03 item 7.01 item 8.01 item 9.01 ◈ Governance Changes

Global Medical REIT completes 1:5 reverse stock split; shares to trade on NYSE Sept 22

Effective Sept 19, 2025, every five shares of common stock converted into one; par value remains $0.001.
August 5, 2025, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

Global Medical REIT Q2 net loss narrows to $0.8M; appoints Mark Decker Jr. CEO; reaffirms AFFO guidance

Net loss narrowed to $0.8M ($0.01/diluted share) from $3.1M loss YoY; FFO $0.20/share, AFFO $0.23/share.
June 23, 2025, 7:59 PM ET leadership materiality 0.70 positive item 5.02 item 7.01 item 9.01 ◈ executive_change ×3

GMRE appoints Mark Decker as CEO; Jeffrey Busch becomes non-executive Chairman

Mark O. Decker, Jr. appointed CEO and President effective June 23, 2025; also joins Board.
May 28, 2025, 7:59 PM ET dividend materiality 0.75 negative item 7.01 item 8.01 item 9.01

Global Medical REIT cuts quarterly common dividend from $0.21 to $0.15 per share

Board declared Q2 2025 common dividend of $0.15/share, down from $0.21; payable July 9 to holders of record June 20.
May 15, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07

Global Medical REIT stockholders elect seven directors, ratify auditor, approve say-on-pay

All seven director nominees elected with at least 38M votes for; no dissident candidates.
May 7, 2025, 7:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q1 net income $2.1M ($0.03/diluted); AFFO $0.22/unit; reaffirms FY2025 AFFO guidance

Net income $2.1M ($0.03/diluted) vs $0.8M ($0.01) prior year; AFFO $0.22/unit vs $0.23.
February 27, 2025, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q4 AFFO $0.22/unit flat YoY; JV with Heitman; 2025 guidance $0.89-$0.93

Q4 2024 net income $1.4M ($0.02/diluted) vs net loss $0.8M (-$0.01) in Q4 2023; full-year net income $0.8M ($0.01) vs $14.8M ($0.23).
January 8, 2025, 6:59 PM ET leadership materiality 0.60 neutral item 5.02 item 7.01 item 8.01 item 9.01

CEO Jeff Busch to step down by June 30, 2025; will remain as non-executive chairman

CEO Jeffrey Busch to leave by earlier of successor appointment or June 30, 2025; to continue as non-executive chairman.
November 15, 2024, 6:59 PM ET other material materiality 0.55 neutral item 7.01 item 9.01

Global Medical REIT updates investor presentation; YTD acquisitions $80.3M at 8.0% cap rate

YTD 2024: $80.3M in acquisitions (15 properties, 254k SF) at 8.0% WA cap rate.
November 6, 2024, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

GMRE Q3 net income $1.8M ($0.03/diluted), FFO $0.19/unit, AFFO $0.22/unit

Rental revenue $34.2M, down 3.7% YoY; net income fell from $3.1M to $1.8M.
September 17, 2024, 7:59 PM ET other material materiality 0.75 positive item 8.01 item 9.01

GMRE signs 15-year triple-net lease with CHRISTUS Health at Beaumont facility after Steward bankruptcy rejection

New 15-year triple-net lease with CHRISTUS Health at Beaumont, TX facility for robotic surgery, orthopedics, emergency services.
August 6, 2024, 7:59 PM ET earnings materiality 0.65 negative item 2.02 item 9.01

Global Medical REIT Q2 net loss $3.1M; Steward risk; $30.8M acquisition closed

Net loss attributable to common stock of $3.1M ($0.05/diluted) vs income $11.8M ($0.18) Q2 2023; includes $3.4M loss on sale.
June 6, 2024, 7:59 PM ET other material materiality 0.10 neutral item 5.07

Global Medical REIT board sets annual say-on-pay vote after stockholder advisory result

Advisory vote: 34,040,745 for every year, 158,991 for two years, 1,098,203 for three years, 566,323 abstained, 13,706,822 broker non-votes.
June 3, 2024, 7:59 PM ET other material materiality 0.15 neutral item 7.01 item 9.01

Global Medical REIT posts updated investor presentation; no material new information

Presentation dated June 3, 2024, posted on company website; no earnings or guidance changes.
May 16, 2024, 7:59 PM ET other materiality 0.35 neutral item 5.02 item 5.07 item 9.01 ◈ Shareholder Votes ×5

Global Medical REIT shareholders approve 1.5M share increase to equity incentive plan at 2024 annual meeting

Stockholders approved amendment to 2016 Equity Incentive Plan, increasing reserved shares by 1,500,000.
May 7, 2024, 7:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases

GMRE Q1 net income $0.8M, AFFO $0.23/share; Steward Health Care files Chapter 11

Net income $0.8M ($0.01/diluted share); FFO $14.9M ($0.21/unit); AFFO $16.5M ($0.23/unit).
April 5, 2024, 7:59 PM ET other material materiality 0.20 neutral item 8.01 item 9.01

Global Medical REIT transfers ATM program to new registration after losing WKSI status

Filed Prospectus Supplement to move ATM Program from Post-Effective Amendment No.1 to No.2.
March 5, 2024, 6:59 PM ET other materiality 0.15 neutral item 8.01 item 9.01

Global Medical REIT moves ATM program to post-effective amendment after losing WKSI status

Company no longer qualifies as well-known seasoned issuer after filing 2023 Form 10-K.
February 27, 2024, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT posts Q4 net loss of $0.8M; full-year AFFO $0.91/share, leverage down to 43.6%

Q4 net loss attributable to common stockholders of $0.8M ($0.01 diluted loss per share), vs net income $0.4M in Q4 2022.
January 9, 2024, 6:59 PM ET other material materiality 0.65 neutral item 1.01 item 9.01 ◈ Material Agreements

Global Medical REIT registers $300M at-the-market equity program with forward sale option

Agreement with 14 agents and 9 forward sellers to sell up to $300M in common stock via ATM offerings.
November 13, 2023, 6:59 PM ET other material materiality 0.30 neutral item 7.01 item 9.01

Global Medical REIT updates investor presentation; portfolio 96.7% occupied, $1.4B gross assets

Portfolio: 185 buildings, 268 tenants, 4.7M sq ft, 96.7% occupancy as of Sept 30, 2023.
November 6, 2023, 6:59 PM ET earnings materiality 0.70 negative item 2.02 item 9.01 ◈ Earnings Releases

GMRE Q3 net income $3.1M ($0.05/diluted), FFO $0.22, revenue $35.5M; occupancy 96.7%

Net income attributable to common stockholders $3.1M ($0.05/diluted) vs $8.1M ($0.12) in prior-year Q3.
August 2, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT Q2 net income $11.8M; core FFO/AFFO down YoY; reduces leverage to 44.5%

Net income $11.8M ($0.18/diluted) vs $2.2M ($0.03) in prior year; includes $12.8M gain on sale.
June 6, 2023, 7:59 PM ET other materiality 0.25 neutral item 7.01 item 9.01

Global Medical REIT updates investor presentation with portfolio data as of March 31, 2023

Portfolio occupancy 97%, weighted average lease term 6.0 years, 188 buildings, 274 tenants.
May 15, 2023, 7:59 PM ET other material materiality 0.15 neutral item 7.01 item 9.01

Global Medical REIT posts updated investor presentation; portfolio metrics as of March 31, 2023

Portfolio occupancy 97%, weighted-average lease term 6.0 years, 188 buildings, 274 tenants.
May 10, 2023, 7:59 PM ET other materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×3

Global Medical REIT annual meeting results: all directors elected, say-on-pay passed, auditor ratified

All seven nominated directors elected with 33.5M to 35.1M votes in favor; broker non-votes of ~14.5M.
May 3, 2023, 7:59 PM ET earnings materiality 0.70 neutral item 2.02 item 9.01 ◈ Earnings Releases

Global Medical REIT Q1 net income $0.7M ($0.01/shr); FFO $15.1M ($0.22/shr); revenue $36.2M (+13.7% YoY)

Net income $0.7M ($0.01 diluted EPS) vs $2.7M ($0.04) YoY; FFO $15.1M ($0.22/shr) vs $16.0M ($0.23); AFFO $16.0M ($0.23) vs $16.8M ($0.24).
February 28, 2023, 6:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT Q4 net income falls to $0.01 EPS; revenue up 19.6% to $36.3M

Q4 net income $0.4M ($0.01 diluted EPS) vs $3.8M ($0.06) YoY; AFFO flat at $0.24/share.
January 23, 2023, 6:59 PM ET leadership materiality 0.20 neutral item 5.02 ◈ executive_change

Director Dr. Roscoe Moore to retire at 2023 Annual Meeting, not seeking re-election

Dr. Roscoe Moore, Jr. notified Board of intent to retire as director, effective at 2023 Annual Meeting.
December 7, 2022, 6:59 PM ET other materiality 0.10 neutral item 5.03 item 9.01 ◈ Governance Changes

Global Medical REIT adopts amended bylaws to comply with federal proxy rules

Board adopted Fourth Amended and Restated Bylaws effective December 7, 2022, to ensure compliance with Rule 14a-19 under the Exchange Act.
November 14, 2022, 6:59 PM ET other material materiality 0.55 neutral item 7.01 item 9.01

Global Medical REIT updates investor presentation with 97% occupancy, $149M YTD acquisitions

Portfolio as of Sept 30, 2022: 97% occupied, 6.4-year WALT, 189 buildings, 4.9M sq ft.
November 2, 2022, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

Global Medical REIT Q3 net income $8.1M, AFFO $0.25/share; adds $150M term loan, 80% fixed-rate debt

Net income $8.1M ($0.12 diluted EPS) vs $3.7M ($0.06) prior year; revenue $35.4M, up 18.1% YoY
October 6, 2022, 7:59 PM ET other material materiality 0.70 negative item 7.01 item 9.01

GMRE tenant Pipeline Health files Chapter 11; rent current, White Rock not primary cause

Pipeline Health System, sole tenant at GMRE's White Rock Medical Center, filed Chapter 11 on Oct 3.
August 3, 2022, 7:59 PM ET earnings materiality 0.70 neutral item 1.01 item 2.02 item 2.03 item 9.01

GMRE Q2 AFFO $0.25/shr (+8.7% YoY); revenue $33.7M; adds $150M term loan

Net income $2.2M ($0.03/shr) vs $2.6M prior year; FFO $0.24/shr, AFFO $0.25/shr.
June 28, 2022, 7:59 PM ET other material materiality 0.40 neutral item 7.01 item 9.01

Global Medical REIT updates investor presentation; termination of $44.6M Belpre property sale disclosed

As of June 24, 2022, purchaser terminated contract to sell Belpre, OH property for $44.6M; asset remains in portfolio.

Executive changes

Appointed

Charles Fitzgerald

Director

XRN · Chiron Real Estate Inc.

Effective: 2026-05-20
Filed: May 20, 2026, 5:24 PM ET

On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.

Appointed

Mark O. Decker, Jr.

Chief Executive Officer and President

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Filed: June 23, 2025, 7:59 PM ET

Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025.

Role change

Jeffrey M. Busch

non-executive Chairman

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Successor: Mark O. Decker, Jr.
Filed: June 23, 2025, 7:59 PM ET

Mr. Busch was removed from his position as Chief Executive Officer and President of the Company, effective June 23, 2025. Mr. Busch will continue to serve on the board of directors of the Company (the “Board”) as non-executive Chairman.

Appointed

Mark O. Decker, Jr.

Director

XRN · Chiron Real Estate Inc.

Effective: 2025-06-23
Filed: June 23, 2025, 7:59 PM ET

the Board also increased the size of the Board from seven directors to eight directors and appointed Mr. Decker as a director effective June 23, 2025

Departed

Dr. Roscoe Moore, Jr.

director

XRN · Chiron Real Estate Inc.

Filed: January 23, 2023, 6:59 PM ET

On January 19, 2023, Dr. Roscoe Moore, Jr. notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Board, effective as of the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”).

Earnings & guidance

2025-FY EPS reported -$0.91 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.65 · Most common event other_material

8 positive 8 negative 34 neutral

source · XRN on sec.gov